Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD 0200390 Dose Ranging Trial in Primary Insomnia
NCT00569972Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Atagabalin in primary insomnia, sponsored by Pfizer. Started Oct 2007; status: completed.
02
Drugs
Atagabalin
03
Conditions
primary insomnia
Beyond the preview
Go deeper on NCT00569972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00569972.